AP-PA03
Pseudomonas aeruginosa infections
Not SpecifiedActive
Key Facts
Indication
Pseudomonas aeruginosa infections
Phase
Not Specified
Status
Active
Company
About Armata Pharmaceuticals
Armata Pharmaceuticals is focused on addressing the global antibiotic resistance crisis through its precision bacteriophage therapeutics, aiming to preserve the healthy human microbiome. The company has built a robust, in-house platform for phage discovery, engineering, and manufacturing, supporting a pipeline targeting multi-drug resistant pathogens like Pseudomonas aeruginosa and Staphylococcus aureus. Led by a seasoned team, including former White House Coronavirus Task Force coordinator Dr. Deborah Birx as CEO, Armata is positioning itself as a leader in the emerging phage therapy space.
View full company profileTherapeutic Areas
Other Pseudomonas aeruginosa infections Drugs
| Drug | Company | Phase |
|---|---|---|
| AP-PA02 | Armata Pharmaceuticals | Phase 1/2 |